The terminology has gotten sloppy. “Growth marketing” means everything from demand generation to community building to viral loops. “ABM” means named-account targeting with orchestrated campaigns. Most B2B companies conflate them or try to run both, creating organizational chaos.
ABM orchestration is the hidden evolution in the space. In 2024-2025, major platforms (Terminus, Demandbase, 6sense) unified email, LinkedIn, display, and CRM into single workflows. You no longer run separate email, LinkedIn, and display campaigns. You run one account-based campaign that coordinates messaging across all channels based on account engagement and buying stage.
Triblio earned its reputation as an accessible account-based marketing platform for mid-market B2B teams. The platform bundles account selection, intent data, email orchestration, and campaign management, making it possible to launch ABM programs without extensive engineering resources.
Partner-led growth (PLG) has emerged as critical go-to-market motion alongside direct sales and product-led growth. Companies using partners to build revenue growth outpace those relying on direct sales alone. Partner-led growth software enables companies to recruit, enable, and scale partner networks efficiently.
Madison Logic has long served as a trusted partner for B2B demand generation and account-based advertising. Their platform combines first-party intent data with media buying capabilities, allowing teams to reach high-value accounts at scale. However, as the ABM market has evolved, new alternatives have emerged offering comparable or superior functionality across intent data integration, programmatic buying, and account targeting precision.
IP targeting has become a cornerstone tactic in B2B advertising and account-based marketing. Rather than target individuals by cookie or email, IP targeting identifies companies visiting your website, then delivers ads to company IP ranges. This enables precise account-level advertising without relying on individual identity.
Pharmaceutical companies face unique ABM challenges distinct from typical B2B software vendors. Sales cycles stretch 18-24 months minimum. Buying committees include doctors, hospital administrators, procurement, compliance, and IT. Regulatory requirements constrain messaging and channel choice. Industry publications and conferences matter more than LinkedIn for visibility. Geographic concentration in medical hub cities drives regional campaign strategies.
Triblio earned its reputation as an accessible account-based marketing platform for mid-market B2B teams. The platform bundles account selection, intent data, email orchestration, and campaign management, making it possible to launch ABM programs without extensive engineering resources.
Partner-led growth (PLG) has emerged as critical go-to-market motion alongside direct sales and product-led growth. Companies using partners to build revenue growth outpace those relying on direct sales alone. Partner-led growth software enables companies to recruit, enable, and scale partner networks efficiently.
Madison Logic has long served as a trusted partner for B2B demand generation and account-based advertising. Their platform combines first-party intent data with media buying capabilities, allowing teams to reach high-value accounts at scale. However, as the ABM market has evolved, new alternatives have emerged offering comparable or superior functionality across intent data integration, programmatic buying, and account targeting precision.
IP targeting has become a cornerstone tactic in B2B advertising and account-based marketing. Rather than target individuals by cookie or email, IP targeting identifies companies visiting your website, then delivers ads to company IP ranges. This enables precise account-level advertising without relying on individual identity.
Pharmaceutical companies face unique ABM challenges distinct from typical B2B software vendors. Sales cycles stretch 18-24 months minimum. Buying committees include doctors, hospital administrators, procurement, compliance, and IT. Regulatory requirements constrain messaging and channel choice. Industry publications and conferences matter more than LinkedIn for visibility. Geographic concentration in medical hub cities drives regional campaign strategies.